Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients-Reference-Cited by-同舟云学术

Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients

Published:2017-10-13 Issue:12 Volume:44 Page:1080-1086
ISSN:0303-6987
Container-title:Journal of Cutaneous Pathology
language:en
Short-container-title:J Cutan Pathol

Author:

Tetzlaff Michael T.¹²^ORCID,Jazaeri Amir A.³,Torres-Cabala Carlos A.¹⁴,Korivi Brinda R.⁵,Landon Genie A.¹,Nagarajan Priyadharsini¹,Choksi Adrienne⁴,Chen Leon⁴,Uemura Marc⁶,Aung Phyu P.¹,Diab Adi⁶,Sharma Padmanee⁷⁸,Davies Michael A.²⁶⁹,Amaria Rodabe⁶,Prieto Victor G.¹⁴,Curry Jonathan L.¹³⁴

Affiliation:

1. Department of Pathology; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Translational and Molecular Pathology; The University of Texas MD Anderson Cancer Center; Houston Texas

3. Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Department of Dermatology; The University of Texas MD Anderson Cancer Center; Houston Texas

5. Department of Diagnostic Imaging; The University of Texas MD Anderson Cancer Center; Houston Texas

6. Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

7. Department of Genitourinary Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

8. Department of Immunology; The University of Texas MD Anderson Cancer Center; Houston Texas

9. Department of Systems Biology; The University of Texas MD Anderson Cancer Center; Houston Texas

Publisher

Wiley

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cup.13044/fullpdf

Reference55 articles.

1. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

2. Improved survival with Ipilimumab in patients with metastatic melanoma (vol 363, pg 711, 2010);Hodi;N Engl J Med,2010

3. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial;Kaufman;Lancet Oncol,2016

4. PD-1 blockade therapy in renal cell carcinoma: current studies and future promises;Massari;Cancer Treat Rev,2015

5. Survival, durable response, and long-term safety in patients with previously treated advanced renal cell carcinoma receiving Nivolumab;McDermott;J Clin Oncol,2015

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Outcomes of dMMR/MSI-H Rectal Cancer Treated With Anti–PD-1–Based Immunotherapy as Curative-Intent Treatment;Journal of the National Comprehensive Cancer Network;2024-04

2. Panniculitis;Rook's Textbook of Dermatology;2024-03-19

3. Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia;Clinical Case Reports;2023-11

4. Immunotherapy-induced exclusively cutaneous sarcoid-like reaction;BMJ Case Reports;2023-07

5. Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies;Cancers;2023-06-09